南京医药集团股份有限公司关于召开2026年第一次临时股东会的提示性公告

Core Viewpoint - Nanjing Pharmaceutical Group Co., Ltd. is set to hold its first extraordinary general meeting of shareholders in 2026 on February 5, 2026, with both on-site and online voting options available [1][2]. Meeting Details - The meeting will take place on February 5, 2026, at 14:00 in Nanjing [1]. - The voting will be conducted through a combination of on-site and online methods using the Shanghai Stock Exchange's voting system [1][2]. - The online voting will be available from 9:15 to 15:00 on the same day [2]. Voting Procedures - Shareholders can vote via the Shanghai Stock Exchange's network voting system, either through a trading terminal or an internet platform [6][7]. - Specific procedures apply for shareholders involved in margin trading, transfer, and other related accounts [3]. Agenda Items - The meeting will review several proposals, including special resolutions and matters requiring separate voting for minority investors [5][6]. - The proposals have been previously approved by the board meetings held on December 18, 2025, and January 19-20, 2026 [5]. Attendance and Registration - Shareholders registered by the close of trading on the registration date are entitled to attend the meeting [11]. - Registration for attendance will occur on February 4, 2026, with specific requirements for both corporate and individual shareholders [12][13]. Additional Services - To facilitate participation, the company will utilize a reminder service to notify shareholders about the meeting and voting options [7].